Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee

Triamcinolone acetonide extended-release (ER) 32 mg (Zilretta(®)) is approved in the USA for the management of osteoarthritis (OA) pain of the knee and is administered as a single, 5 mL intra-articular (IA) injection. Although the therapeutic effects from IA corticosteroids are typically short-lived...

Descripción completa

Detalles Bibliográficos
Autores principales: Paik, Julia, Duggan, Sean T., Keam, Susan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Adis Drug Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437125/
https://www.ncbi.nlm.nih.gov/pubmed/30847805
http://dx.doi.org/10.1007/s40265-019-01083-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437125/
https://www.ncbi.nlm.nih.gov/pubmed/30847805
http://dx.doi.org/10.1007/s40265-019-01083-3

Ejemplares similares